[Treatment of low-risk pediatric lymphocyte-predominant Hodgkin lymphoma].
St. Anna Kinderkrebsforschung, St. Anna Kinderspital, UKKJ, MUW, Kinderspitalgasse 6, 1090, Wien, Österreich. georg.mann@stanna.at.
Georg
G
Mann
St. Anna Kinderkrebsforschung, St. Anna Kinderspital, UKKJ, MUW, Kinderspitalgasse 6, 1090, Wien, Österreich.
Wolfgang
W
Holter
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy / Q000379:methods / Q000401:mortality; D005260:Female; D006689:Hodgkin Disease / Q000401:mortality* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D007223:Infant; D038622:Internationality; D008197:Lymph Node Excision / Q000379:methods* / Q000401:mortality*; D008214:Lymphocytes / Q000473:pathology*; D008297:Male; D015995:Prevalence; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents